(Q85037985)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Hypothyroidism in patients with renal cell carcinoma: blessing or curse? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Manuela Schmidinger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Ursula M Vogl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Wolfgang Lamm

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Harald Heinzl

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Andrea Haitel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Martin Clodi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Gero Kramer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Christoph C Zielinski

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

15 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

534-544

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

NCCN clinical practice guidelines in oncology: kidney cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Targeted therapies for metastatic renal cell carcinoma: an overview of toxicity and dosing strategies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

A Novel Tyrosine-Kinase Selective Inhibitor, Sunitinib, Induces Transient Hypothyroidism by Blocking Iodine Uptake

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Phase II trial of sorafenib in advanced thyroid cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Propylthiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Association between development of hypothyroidism and improved survival in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Is there a need to redefine the upper normal limit of TSH?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Thyroid hormone induces cerebellar astrocytes and C6 glioma cells to secrete mitogenic growth factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Subclinical thyroid disease: scientific review and guidelines for diagnosis and management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Thyroid hormone and growth hormone interact to regulate insulin-like growth factor-I messenger ribonucleic acid and circulating levels in the rat

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25422

7 January 2021

Identifiers

DOI

10.1002/CNCR.25422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20845482%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference